Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Stem Cells International
Volume 2016, Article ID 4078215, 4 pages
http://dx.doi.org/10.1155/2016/4078215
Clinical Study

Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children

1Banco de Sangre, Hospital General de Ecatepec las Américas, Simón Bolivar esq. Libertadores de América Fracc. las Américas, 55076 Ecatepec de Morelos, MEX, Mexico
2Area de Virología, Laboratorio de Microbiología y Enfermedades Infecciosas, Hospital Infantil de México Federico Gómez, Mexico
3Departamento de Oncología, Instituto Nacional de Pediatría, Mexico
4Laboratorio de Hematología e Investigación, Hospital General de México, OD and Laboratorio Clínico, Central Hospital Infantil de México Federico Gómez, Ciudad de México, DF, Mexico
5Departamento de Hematología Pediátrica, UMAE CMN la Raza IMSS, Mexico

Received 2 October 2015; Accepted 16 November 2015

Academic Editor: Mahendra S. Rao

Copyright © 2016 José Eugenio Vázquez Meraz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Zovein and E. C. Forsberg, “Hematopoietic development at high altitude: blood stem cells put to the test,” Development, vol. 142, no. 10, pp. 1728–1732, 2015. View at Publisher · View at Google Scholar
  2. O. Blau, “Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia,” Frontiers in Bioscience, vol. 19, no. 1, pp. 171–180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. B. McCredie, E. M. Hersh, and E. J. Freireich, “Cells capable of colony formation in the peripheral blood of man,” Science, vol. 171, no. 3968, pp. 293–294, 1971. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Tridente, “Pluripotent growth factors,” in Adverse Events with Biomedicines: Prevention Through Understanding, pp. 583–585, Springer, Milan, Italy, 2014. View at Publisher · View at Google Scholar
  5. L. B. To, K. M. Shepperd, D. N. Haylock et al., “Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood,” Experimental Hematology, vol. 18, no. 5, pp. 442–447, 1990. View at Google Scholar · View at Scopus
  6. M. K. Angelopoulou, P. Tsirkinidis, G. Boutsikas, T. P. Vassilakopoulos, and P. Tsirigotis, “New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients,” BioMed Research International, vol. 2014, Article ID 835138, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Carella, F. Frassoni, N. Pollicardo et al., “Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia,” British Journal of Haematology, vol. 89, no. 3, pp. 535–538, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Reiser, A. Josting, A. Draube et al., “Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization,” Bone Marrow Transplantation, vol. 23, no. 12, pp. 1223–1228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sorasio, M. Bonferroni, M. Grasso et al., “Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience,” Biology of Blood and Marrow Transplantation, vol. 20, no. 5, pp. 717–723, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. D. Kotasek, K. M. Shepherd, R. E. Sage et al., “Factors affecting blood stem cell collections following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors,” Bone Marrow Transplantation, vol. 9, no. 1, pp. 11–17, 1992. View at Google Scholar · View at Scopus
  11. G. Milone, M. Martino, A. Spadaro et al., “Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs,” British Journal of Haematology, vol. 164, no. 1, pp. 113–123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Vantelon, S. Koscielny, P. Brault et al., “Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice,” Bone Marrow Transplantation, vol. 25, no. 5, pp. 495–499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Gómez-Espuch, J. M. Moraleda Jiménez, F. Ortuño et al., “Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotherapeutic agent, associated with rhG-CSF,” Bone Marrow Transplantation, vol. 25, no. 3, pp. 231–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Gianni, M. Bregni, A. Stern et al., “Granulocyte-macrophage colony–stimulating factor to harvest circulating hematopoietic stem cell for auto transplantations,” The Lancet, vol. 334, no. 8663, pp. 580–585, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Socinski, A. Elias, L. Schnipper, S. Cannistra, K. Antman, and J. Griffin, “Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man,” The Lancet, vol. 331, no. 8596, pp. 1194–1198, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Fukuda, S. Kojima, K. Matsumoto, and T. Matsuyama, “Auto transplantation of peripheral blood stem cells mobilized by chemotherapy and recombinant human granulocyte colony-stimulating factor in childhood neuroblastoma and non-Hodgkin’s lymphoma,” British Journal of Haematology, vol. 80, no. 3, pp. 327–331, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Costa, G. L. Uy, P. N. Hari et al., “Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous transplantation,” Blood, vol. 124, no. 21, p. 2447, 2014. View at Google Scholar
  18. S. Emir, H. A. Demir, T. Aksu, A. Kara, M. Özgüner, and B. Tunç, “Use of plerixafor for peripheral blood stem cell mobilization failure in children,” Transfusion and Apheresis Science, vol. 50, no. 2, pp. 214–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Takaue, T. Watanabe, Y. Kawano et al., “Isolation and storage of peripheral blood hematopoietic stem cells for autotrasplantation into children with cancer,” Blood, vol. 74, no. 4, pp. 1245–1251, 1989. View at Google Scholar · View at Scopus
  20. K. A. de Brito Eid, E. C. M. Miranda, and S. dos Santos Aguiar, “Mobilization and collection of CD34+ cells for autologous transplantation of peripheral blood hematopoietic progenitor cells in children: analysis of two different granulocyte-colony stimulating factor doses,” Revista Brasileira de Hematologia e Hemoterapia, vol. 37, no. 3, pp. 160–166, 2015. View at Publisher · View at Google Scholar
  21. L. C. Lasky, B. Bostrom, J. Smith, T. J. Moss, and N. K. C. Ramsay, “Clinical collection and use of peripheral blood stem cells in pediatric patients,” Transplantation, vol. 47, no. 4, pp. 613–616, 1989. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Körbling and H. Martin, “Transplantation of hemapheresis-derived hemopoietic stem cells: a new concept in the treatment of patients with malignant lymphohemopoietic disorders,” Plasma Therapy and Transfusion Technology, vol. 9, no. 1, pp. 119–132, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Rowlings, C. A. Rowling, L. B. To et al., “a comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4gr/m2 in patients with advanced cancer,” Australian & New Zealand Journal of Medicine, vol. 22, article 600, 1992. View at Google Scholar
  24. J. W. Sweetenham and M. L. Turner, “Haemopoietic progenitor homing and mobilization,” British Journal of Haematology, vol. 94, no. 4, pp. 592–596, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. W. P. Sheridan, R. M. Fox, C. G. Begley et al., “Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy,” The Lancet, vol. 339, no. 8794, pp. 640–644, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. N. J. Chao, J. R. Schriber, K. Grimes et al., “Granulocyte colony-stimulating factor ‘mobilized’ peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy,” Blood, vol. 81, no. 8, pp. 2031–2035, 1993. View at Google Scholar · View at Scopus
  27. D. C. Link, “Mechanisms of granulocyte colony-stimulating factor induced hematopoietic progenitor-cell mobilization,” Seminars in Hematology, vol. 37, supplement 2, pp. 25–32, 2000. View at Publisher · View at Google Scholar · View at Scopus